Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era?
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 69, doi. 10.1159/000495139
- By:
- Publication type:
- Article
Works matching IS 22969381 AND DT 2019 AND VI 5 AND IP 2
Results: 9
1
2
Analysis of Nationwide Data to Determine the Incidence and Diagnosed Prevalence of Autosomal Dominant Polycystic Kidney Disease in the USA: 2013–2015.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 107, doi. 10.1159/000494923
- By:
- Publication type:
- Article
3
Front & Back Matter.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. N.PAG, doi. 10.1159/000499725
- Publication type:
- Article
4
Active Vitamin D in Chronic Kidney Disease: Getting Right Back Where We Started from?
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 59, doi. 10.1159/000495138
- By:
- Publication type:
- Article
5
Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 118, doi. 10.1159/000494924
- By:
- Publication type:
- Article
6
Burden, Access, and Disparities in Kidney Disease.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
7
Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 100, doi. 10.1159/000494724
- By:
- Publication type:
- Article
8
Individual and Combined Relationship between Reduced eGFR and/or Increased Urinary Albumin Excretion Rate with Mortality Risk among Insulin-Treated Patients with Type 2 Diabetes in Routine Practice.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 91, doi. 10.1159/000493731
- By:
- Publication type:
- Article
9
The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword.
- Published in:
- Kidney Diseases, 2019, v. 5, n. 2, p. 81, doi. 10.1159/000493684
- By:
- Publication type:
- Article